URINE DRUG TESTING FOR WORKER’S COMPENSATION
Helping clinicians improve claimant outcomes
As a worker’s’ compensation professional, your goal is to get claimants back to work as soon as they are able while efficiently managing costs. Controlling pain is an important part of many injured worker’s’ treatment, yet it can be a substantial expense. Up to 86% of all worker’s’ compensation claimants receive opioids for pain management. Medication monitoring for worker’s comp provides important objective information to clinicians prescribing opioids and other controlled substances for the treatment of injured worker’s.
There is evidence that urine drug screens can identify aberrant opioid use and other substance use that otherwise is not apparent to the treating physician. In fact, ACOEM Guidelines recommend that injured worker’s receiving chronic opioid therapy be monitored through routine assessment that includes urine toxicology screens
The Truetox Advantage provides
- Monitoring and support regarding medication therapy, particularly controlled substances
- The ability to identify recent use of prescription medications, non-prescribed medications and illicit substances
- The detection of medications that may result in a drug-drug interaction
- The identification of possible illicit drug or medication abuse, misuse or diversion